Marvell (MRVL) PT Raised to $300 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
Tweet
Share
E-mailGet Alerts MRVL Hot Sheet
Price: $237.09 +4.06%
Rating Summary:
51 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 21 | New: 15
Rating Summary:
51 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 21 | New: 15
Join SI Premium – FREE
Morgan Stanley analyst Joseph Moore raised the price target on Marvell (NASDAQ: MRVL) to $300.00 (from $268.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Marvell Technology shares rise on analyst support
- CenterPoint Energy (CNP) PT Lowered to $45 at BMO Capital
- Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
